National symposium focuses on bleeding and thrombotic disorders
On Dec. 4, Mayo Clinic Laboratories will host the Friday Satellite Symposium A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis, preceding the 62nd American Society of Hematology Annual Meeting and Exposition.
This symposium will include the following presentations:
- "New Therapies for Hemophilia: Options and Assays"
- "Advances in the Diagnosis of Heparin-Induced Thrombocytopenia"
- "Platelet Esoteric Testing: When and Why"
- "Rationale Application of Next-Generation Sequencing Technologies in Coagulation Disorders"
- "Measurement of Direct-Acting Anticoagulants: Clinical and Laboratory Issues"
Program participants will learn about emerging diagnostic and therapeutic aspects of bleeding and thrombotic disorders. Specific topics to be discussed include:
- Choosing the right type of factor assays for monitoring newer factor and nonfactor products for hemophilia management.
- The optimal role of newer technologies, such as next-generation sequencing, for diagnosis of coagulation disorders.
- The optimal laboratory evaluation of inherited platelet disorders.
- An update on recent advances in the diagnosis of heparin-induced thrombocytopenia.
- The role of measuring direct-acting oral anticoagulants.
Using test-ordering algorithms based on data derived from the Mayo Clinic Special Coagulation Laboratory practice and the literature, program faculty will illustrate how costly and unnecessary biochemical, phenotypic, and genetic testing can be avoided, while enhancing high-quality medical care.
The symposium agenda, information about continuing education credits, and registration details are available on the event website. Registration is limited to 300 attendees. The deadline to register is Thursday, Dec. 3, at 5 p.m. CT.